$DJI 0.14% NDX 0.31% SPX 0.07% VIX 3.38% News 1
Mon, Sep 16 4:50am

INVA $11.46 0.15 (1.29%)
Innoviva Inc

INVA Profile

Market Cap 1.17 Billion
INVA Description

Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes RELVAR/BREO/ELLIPTA, ANORO, ELLIPTA, TRELEGY, ELLIPTA, and others. The firm collaborates with and receives funding from GlaxoSmithKline.

Visit Website

INVA Earnings

EPS 0.37 P/E Ratio 3.94
Previous Wed, May 1, 2019
Latest Wed, Jul 24, 2019 (54 days ago) -13.18%

INVA Dividend

Yield --
Ex-Date --
Pay Date --
History 5 Payments (Quarterly)

INVA Charts

1 Year
Aug 27, 2019
Jan 29, 2019

Symbol Price Day Δ YTD Δ
INVA $11.46 -1.29% -33.76%


Symbol Surfing

How can we make Symbol Surfing better?


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy